Sectors

CSBR
Champions Oncology, Inc.
5.29
1 x 5.07
1 x 5.14
bid
ask
+
0.15
2.92%
09:36 AM
timesize
Ytd-23.44%
1y-17.08%
5.11
day range
5.29
5.00
52 week range
8.74
Open5.15Prev Close5.14Low5.11High5.29Mkt Cap73.50M
Vol0.00Avg Vol9.02KEPS-0.16P/E-33.06Forward P/E42.68
Beta0.40Short Ratio20.86Inst. Own49.09%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning03-1250-d Avg5.91200-d Avg6.261yr Est8.00

CSBR News

CSBR Stock Dips Post Q4 Earnings Despite Record Revenue Growth, AI Push
zacks.com
CSBR Stock Dips Post Q4 Earnings Despite Record Revenue Growth, AI Push

Champions Oncology reports fourth-quarter fiscal 2026 growth as revenue gains, margin improvement an

Champions Oncology, Inc. (CSBR) Q4 2026 Earnings Call Transcript
seekingalpha.com
Champions Oncology, Inc. (CSBR) Q4 2026 Earnings Call Transcript

Champions Oncology, Inc. (CSBR) Q4 2026 Earnings Call Transcript

Champions Oncology Q4 Earnings Call Highlights
marketbeat.com
Champions Oncology Q4 Earnings Call Highlights

Champions Oncology NASDAQ: CSBR reported record revenue for fiscal 2026 and positive adjusted EBITDA

benzinga.com
Champions Oncology Q4 Adj. EPS $0.01 Beats $(0.05) Estimate, Sales $13.835M Beat $12.886M Estimate

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.01 per share which beat the analy

Champions Oncology Reports Record Annual Revenue of $59 Million
accessnewswire.com
Champions Oncology Reports Record Annual Revenue of $59 Million

Delivers Fourth Consecutive Quarter of Positive Adjusted EBITDA HACKENSACK, NJ / ACCESS Newswire / J

CSBR vs. CTKB: Which Life Sciences Stock Has Better Long-Term Upside?
zacks.com
CSBR vs. CTKB: Which Life Sciences Stock Has Better Long-Term Upside?

Champions Oncology and Cytek Biosciences have different growth drivers and valuations, but which lif

2 Microcaps With Gross Margin Catalysts
zacks.com
2 Microcaps With Gross Margin Catalysts

CSBR and CEPL have levers in place for Gross Margin improvement.

Zacks Initiates Coverage of Champions Oncology With Neutral Recommendation
zacks.com
Zacks Initiates Coverage of Champions Oncology With Neutral Recommendation

Discover why Zacks rates Champions Oncology as "Neutral", being the first on Wall Street to initiate

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 2026
accessnewswire.com
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 27, 202

HACKENSACK, NJ / ACCESS Newswire / July 20, 2026 / Champions Oncology, Inc. (NASDAQ:CSBR), a global

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

Champions Oncology (NASDAQ:CSBR) Share Price Passes Below Two Hundred Day Moving Average   – Time to Sell?
defenseworld.net
Champions Oncology (NASDAQ:CSBR) Share Price Passes Below Two Hundred Day Moving Average – Time to

Champions Oncology, Inc. (NASDAQ: CSBR - Get Free Report) shares passed below its two hundred day mo

Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
accessnewswire.com
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026

Eight studies demonstrate how clinically relevant models and integrated data can reduce translationa

Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
accessnewswire.com
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy

Appointment underscores Champions' focus on leveraging clinically relevant data to power next-genera

Champions Oncology, Inc. (CSBR) Q3 2026 Earnings Call Transcript
seekingalpha.com
Champions Oncology, Inc. (CSBR) Q3 2026 Earnings Call Transcript

Champions Oncology, Inc. (CSBR) Q3 2026 Earnings Call Transcript

benzinga.com
Champions Oncology Q3 Adj. EPS $0.04 Misses $0.09 Estimate, Sales $16.559M Miss $16.613M Estimate

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.04 per share which missed the ana

Champions Oncology Reports Revenue of $16.6 Million
accessnewswire.com
Champions Oncology Reports Revenue of $16.6 Million

Company remains on track to deliver year-over-year revenue growth and positive adjusted EBITDA for t

Earnings Scheduled For March 12, 2026
benzinga.com
Earnings Scheduled For March 12, 2026

Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
accessnewswire.com
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026

HACKENSACK, NJ / ACCESS Newswire / March 5, 2026 / Champions Oncology, Inc. (CSBR), a leading transl

Champions Oncology, Inc. (CSBR) Q2 2026 Earnings Call Transcript
seekingalpha.com
Champions Oncology, Inc. (CSBR) Q2 2026 Earnings Call Transcript

Champions Oncology, Inc. (CSBR) Q2 2026 Earnings Call Transcript

Market Today: Ford axes Lightning, iRobot bankrupt, Nvidia-China chips
gurufocus.com
Market Today: Ford axes Lightning, iRobot bankrupt, Nvidia-China chips

Stock News Ford pivots from full EV to hybrids and storage: Ford Motor (F) will discontinue the allâ

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

benzinga.com
Champions Oncology Q2 Adj. EPS $0.06 Beats $0.01 Estimate, Sales $15.035M Beat $14.042M Estimate

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.06 per share which beat the analy

Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million
accessnewswire.com
Champions Oncology Reports Record Quarterly Service Revenue of $14.9 Million

We remain on track to deliver year-over-year revenue growth and to generate positive adjusted EBITDA

Top Stocks With Earnings This Week: Micron, FuelCell, Carnival and More
benzinga.com
Top Stocks With Earnings This Week: Micron, FuelCell, Carnival and More

Investors are prepping for this week's earnings reports which include homebuilders, several appa

First Look: iRobot Bankruptcy, Netflix-WBD Fight, Tesla Robotaxi
gurufocus.com
First Look: iRobot Bankruptcy, Netflix-WBD Fight, Tesla Robotaxi

Stock News iRobot enters Chapter 11: iRobot (IRBT) filed for Chapter 11 and agreed to be acquired by

Earnings Scheduled For December 15, 2025
benzinga.com
Earnings Scheduled For December 15, 2025

Dow Settles Lower But Records Weekly Gain: Investor Sentiment Declines, Greed Index Moves To 'Fear' Zone
feeds.benzinga.com
Dow Settles Lower But Records Weekly Gain: Investor Sentiment Declines, Greed Index Moves To 'Fear'

U.S. stocks fell on Friday, with the S&P 500 dropping over 1% and the Dow gaining 1.1%. The Fear and

Dow Settles Lower But Records Weekly Gain: Investor Sentiment Declines, Greed Index Moves To 'Fear' Zone
benzinga.com
Dow Settles Lower But Records Weekly Gain: Investor Sentiment Declines, Greed Index Moves To 'Fear'

U.S. stocks fell on Friday, with the S&P 500 dropping over 1% and the Dow gaining 1.1%. The Fear

Argenx, Navan And 3 Stocks To Watch Heading Into Monday
benzinga.com
Argenx, Navan And 3 Stocks To Watch Heading Into Monday

Stock futures up, focus on HYFT, ARGX, NAVN, AXR, CSBR as they report earnings. Top 2 energy stocks

Insights Ahead: Champions Oncology's Quarterly Earnings
benzinga.com
Insights Ahead: Champions Oncology's Quarterly Earnings

Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025
accessnewswire.com
Champions Oncology to Announce Second Quarter Financial Results on Monday, December 15, 2025

HACKENSACK, NJ / ACCESS Newswire / December 8, 2025 / Champions Oncology, Inc. (CSBR), a leading tra

benzinga.com
Champions Oncology Q1 Adj. EPS $0.02 Beats $(0.01) Estimate, Sales $13.995M Beat $13.513M Estimate

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.02 per share which beat the analy

benzinga.com
Earnings Scheduled For September 15, 2025

benzinga.com
Insights Ahead: Champions Oncology's Quarterly Earnings

4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week
benzinga.com
4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past Week

Several biotech stocks have seen their strength fade over the past week, with their Momentum scores

benzinga.com
Earnings Scheduled For July 23, 2025

benzinga.com
Earnings Scheduled For March 11, 2025

benzinga.com
Earnings Scheduled For March 12, 2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for it

benzinga.com
Earnings Scheduled For December 12, 2023

Companies Reporting Before The Bell • CSP (NASDAQ:CSPI) is likely to report earnings for its fourth

benzinga.com
Earnings Scheduled For March 15, 2023

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly

benzinga.com
Earnings Scheduled For March 15, 2022

  Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quart

benzinga.com
Earnings Scheduled For July 22, 2021

  Companies Reporting Before The Bell • Champions Oncology, Inc. - Common Stock (NASDAQ:CSBR) is e

benzinga.com
Stocks That Hit 52-Week Highs On Tuesday

This morning 279 companies reached new 52-week highs.

benzinga.com
Earnings Scheduled For March 11, 2021

  Companies Reporting Before The Bell • Celsius Holdings (NASDAQ:CELH) is estimated to report quar

benzinga.com
Earnings Scheduled For July 27, 2020

Companies Reporting Before The Bell • Hasbro Inc. (NASDAQ:HAS) is expected to report quarterly earn

benzinga.com
Stocks That Hit 52-Week Lows On Monday

Stocks That Hit 52-Week Lows On Monday

benzinga.com
Stocks Which Set New 52-Week High Friday, September 14th

Stocks Which Set New 52-Week High Friday, September 14th